OPKO Health, Inc. Equity Securities, FV-NI, Gain (Loss)
OPKO Health, Inc. (OPK) reported Equity Securities, FV-NI, Gain (Loss) of -$1.22 million for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-08-28
- OPKO Health, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2026-06-30 was $2.43M, a 723.39% increase year-over-year.
- OPKO Health, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2026-03-31 was -$3.65M, a 268.41% decline year-over-year.
- OPKO Health, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2025-12-31 was $1.30M, a 98.24% decline year-over-year.
- OPKO Health, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2025-09-30 was $325.00K, a 3150.00% increase year-over-year.
- OPKO Health, Inc. equity securities, fv-ni, gain (loss) for fiscal 2025 was $4.08M, a 94.47% decline from fiscal 2024.
- OPKO Health, Inc. equity securities, fv-ni, gain (loss) for fiscal 2024 was $73.87M.
- OPKO Health, Inc. equity securities, fv-ni, gain (loss) for fiscal 2023 was -$532.00K.
- OPKO Health, Inc. equity securities, fv-ni, gain (loss) for fiscal 2022 was -$3.58M.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.43M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | -$1.22M 10-Q/A · filed 2026-08-28 | $82.00K derived: sum of 3 quarters · filed 2026-08-28 | $407.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | -$3.65M 10-Q/A · filed 2026-08-28 | -$2.35M derived: sum of 2 quarters · filed 2026-08-28 | -$2.02M derived: sum of 3 quarters · filed 2026-08-28 | -$1.73M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.62M derived: sum of 2 quarters · filed 2026-02-26 | $1.92M derived: sum of 3 quarters · filed 2026-08-28 | $4.08M 10-K · filed 2026-02-26 |
| 2025-09-30 | $325.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | $620.00K derived: sum of 2 quarters · filed 2026-08-28 | $2.79M 10-Q · filed 2025-10-29 | $76.61M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | $295.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $2.46M 10-Q/A · filed 2026-08-28 | $76.29M derived: sum of 3 quarters · filed 2026-08-28 | $76.30M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | $2.17M 10-Q/A · filed 2026-08-28 | $76.00M derived: sum of 2 quarters · filed 2026-08-28 | $76.00M derived: sum of 3 quarters · filed 2026-08-28 | $75.97M derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | $73.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $73.84M derived: sum of 2 quarters · filed 2026-02-26 | $73.81M derived: sum of 3 quarters · filed 2026-02-26 | $73.87M 10-K · filed 2026-02-26 |
| 2024-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$24.00K derived: sum of 2 quarters · filed 2025-10-29 | $43.00K 10-Q · filed 2025-10-29 | -$78.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $33.00K 10-Q · filed 2025-07-31 | -$88.00K derived: sum of 3 quarters · filed 2026-02-26 | -$181.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $67.00K 10-Q · filed 2025-05-01 | -$54.00K derived: sum of 2 quarters · filed 2026-02-26 | -$147.00K derived: sum of 3 quarters · filed 2026-02-26 | -$360.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$214.00K derived: sum of 2 quarters · filed 2026-02-26 | -$427.00K derived: sum of 3 quarters · filed 2026-02-26 | -$532.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$306.00K derived: sum of 2 quarters · filed 2024-11-07 | -$411.00K 10-Q · filed 2024-11-07 | -$990.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$318.00K 10-Q · filed 2024-08-07 | -$897.00K derived: sum of 3 quarters · filed 2025-03-03 | -$1.18M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$105.00K 10-Q · filed 2024-05-07 | -$684.00K derived: sum of 2 quarters · filed 2025-03-03 | -$965.00K derived: sum of 3 quarters · filed 2025-03-03 | -$2.52M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$579.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$860.00K derived: sum of 2 quarters · filed 2025-03-03 | -$2.42M derived: sum of 3 quarters · filed 2025-03-03 | -$3.58M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.84M derived: sum of 2 quarters · filed 2023-11-06 | -$3.00M 10-Q · filed 2023-11-06 | -$5.32M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | -$1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$2.72M 10-Q · filed 2023-08-03 | -$5.04M derived: sum of 3 quarters · filed 2024-03-01 | -$5.96M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | -$1.16M 10-Q · filed 2023-05-03 | -$3.48M derived: sum of 2 quarters · filed 2024-03-01 | -$4.40M derived: sum of 3 quarters · filed 2024-03-01 | -$5.77M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | -$2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$3.24M derived: sum of 2 quarters · filed 2024-03-01 | -$4.61M derived: sum of 3 quarters · filed 2024-03-01 | -$1.83M 10-K · filed 2024-03-01 |
| 2021-09-30 | -$917.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.29M derived: sum of 2 quarters · filed 2022-11-08 | $491.00K 10-Q · filed 2022-11-08 | $1.91M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.41M 10-Q · filed 2022-08-04 | $2.83M derived: sum of 3 quarters · filed 2023-02-27 | |
| 2021-03-31 | $2.78M 10-Q · filed 2022-05-09 | $4.20M derived: sum of 2 quarters · filed 2023-02-27 | ||
| 2020-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $10.38M 10-K · filed 2023-02-27 | ||
| 2020-09-30 | $8.96M 10-Q · filed 2021-10-28 | |||
| 2019-12-31 | -$7.44M 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $2.75M 10-K · filed 2021-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |